Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.44324 | 56 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.68725 | 62 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.45064 | 57 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.10226 | 67 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.42258 | 57 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.4753 | 55 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.43943 | 54 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.41302 | 56 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.4334 | 57 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.44759 | 57 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.65794 | 61 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.4359 | 57 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.42925 | 56 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.41519 | 56 |